Collectively, 91% of lung NETs have a functional loss of either p53 or PHLDA3 (Figure 2A), suggesting that defects in this p53-PHLDA3 pathway play a major role in lung NET tumorigenesis [13]. This evidence concerns the gene PHLDA3 and medical procedure.